Skip to main content
News

Noble Life Sciences Announces Its Collaboration With George Mason University To Access The National Center For Biodefense And Infectious Diseases BSL-3 Facility | Noble Life Sciences

By December 27, 2022No Comments
Noble Life Sciences announces its collaboration with George Mason University

Noble Life Sciences announces its collaboration with George Mason UniversitySykesville, MD, and Fairfax, VA, December 21, 2020 – Noble Life Sciences (NLS), a preclinical contract research organization located in Sykesville, MD, has signed a Collaboration Agreement with George Mason University (Mason) to access the National Center for Biodefense and Infectious Diseases (NCBID) BSL-3 facility located within their Biomedical Research Laboratory at Mason’s Science and Technology Campus in Manassas. The Agreement enables NLS to perform federal and non-federally funded BSL-3 animal model projects to support the development of new antiviral and antibacterial agents against infectious and resistant pathogens.

Image: https://noblelifesci.com

{iframe}https://noblelifesci.com/collaboration-with-george-mason-university/{/iframe}

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.